Pete DePhillips
Papers
2
Total Citations
44
H-Index
2
About
Pete DePhillips is a leading figure in the advancement of laboratory automation and bioanalytical method development, with a specialized focus on immunoassays and vaccine research. His work is defined by a rigorous, data-driven approach to optimizing complex biological assays for high-throughput environments. DePhillips’s most influential contribution, "Optimizing ELISAs for precision and robustness using laboratory automation and statistical design of experiments" (2008, 40 citations), established a foundational framework for enhancing the reliability and efficiency of ELISA workflows. This work has become a key reference for researchers seeking to transition manual, variable assays into robust, automated processes. More recently, DePhillips has applied his expertise to a critical global health challenge, co-authoring "Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development" (2024). This paper directly addresses the urgent need for effective vaccines against dengue fever, which threatens half the world’s population. By developing a fully automated, high-throughput assay, his work accelerates the development and quality control of live-attenuated tetravalent dengue vaccines, demonstrating a powerful synergy between advanced automation and life-saving vaccine technology.
Research Focus
Key Achievements
Top Papers
- 1
- 2